BCAR1 | Breast cancer anti-estrogen resistance 1 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
BDH1 | 3-hydroxybutyrate dehydrogenase, type 1 | Candidate cardiovascular disease genes Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
BIRC5 | Baculoviral IAP repeat containing 5 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
BMP8A | Bone morphogenetic protein 8a | Predicted secreted proteins
| | | | | Tissue enriched |
BSCL2 | Berardinelli-Seip congenital lipodystrophy 2 (seipin) | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CAB39 | Calcium binding protein 39 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CAB39L | Calcium binding protein 39-like | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CACNA1D | Calcium channel, voltage-dependent, L type, alpha 1D subunit | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
CACNA2D2 | Calcium channel, voltage-dependent, alpha 2/delta subunit 2 | FDA approved drug targets Predicted intracellular proteins Transporters
| | | | | Tissue enriched |
CAMK2G | Calcium/calmodulin-dependent protein kinase II gamma | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CARTPT | CART prepropeptide | FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CASR | Calcium-sensing receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CCL2 | Chemokine (C-C motif) ligand 2 | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CD38 | CD38 molecule | Cancer-related genes CD markers Enzymes Predicted intracellular proteins
| | | | | Mixed |
CDK1 | Cyclin-dependent kinase 1 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
CDK16 | Cyclin-dependent kinase 16 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
CEP19 | Centrosomal protein 19kDa | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CHRM3 | Cholinergic receptor, muscarinic 3 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
CITED1 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
CLOCK | Clock circadian regulator | Enzymes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
CNR1 | Cannabinoid receptor 1 (brain) | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CPEB1 | Cytoplasmic polyadenylation element binding protein 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CPEB2 | Cytoplasmic polyadenylation element binding protein 2 | Predicted intracellular proteins
| | | | | Expressed in all |
CPT1A | Carnitine palmitoyltransferase 1A (liver) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CRH | Corticotropin releasing hormone | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CRK | V-crk avian sarcoma virus CT10 oncogene homolog | Predicted intracellular proteins
| | | | | Expressed in all |
CRY1 | Cryptochrome circadian clock 1 | Predicted intracellular proteins
| | | | | Expressed in all |
CRY2 | Cryptochrome circadian clock 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CYB5R4 | Cytochrome b5 reductase 4 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
DOC2B | Double C2-like domains, beta | Predicted intracellular proteins
| | | | | Mixed |
DOK2 | Docking protein 2, 56kDa | Predicted intracellular proteins
| | | | | Mixed |
DOK4 | Docking protein 4 | Predicted intracellular proteins
| | | | | Expressed in all |
DOK6 | Docking protein 6 | Predicted intracellular proteins
| | | | | Mixed |
DOK7 | Docking protein 7 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DRD2 | Dopamine receptor D2 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
EEF2K | Eukaryotic elongation factor-2 kinase | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
EFNA5 | Ephrin-A5 | Cancer-related genes Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
EIF4B | Eukaryotic translation initiation factor 4B | Predicted intracellular proteins
| | | | | Expressed in all |
EIF4E | Eukaryotic translation initiation factor 4E | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
EIF4G1 | Eukaryotic translation initiation factor 4 gamma, 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ERO1LB | ERO1-like beta (S. cerevisiae) | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
FABP2 | Fatty acid binding protein 2, intestinal | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
FABP3 | Fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) | Candidate cardiovascular disease genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
FADS1 | Fatty acid desaturase 1 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
FAM3B | Family with sequence similarity 3, member B | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FAM3D | Family with sequence similarity 3, member D | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FETUB | Fetuin B | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
FFAR3 | Free fatty acid receptor 3 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FFAR4 | Free fatty acid receptor 4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |